Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleLetter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?AuthorsOrfanoudaki, Eleni; Drygiannakis, Ioannis; Koutroubakis, Ioannis E.AbstractLinked Content This article is linked to Schmitz et al papers. To view this article visit https://doi.org/10.1111/apt.14453.SubjectsINFLIXIMAB; CROHN'S diseasePublicationAlimentary Pharmacology & Therapeutics, 2018, Vol 48, Issue 9, p1037ISSN0269-2813Publication typeLetter to the EditorDOI10.1111/apt.14980